Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-10-31

Clinical Trial Update: Ex Vivo Effect of Surfactant Protein D on Pulmonary Cells in Patients With Asthma and Pilot Study to Assess Local Inflammation Induced by Segmental Allergen Challenge by Magnetic Resonance Imaging [NA]

View source ↗

Summary

This clinical trial update reports on an ex vivo study of surfactant protein D effects on pulmonary cells in patients with mild intermittent asthma, and a pilot…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Surfactant Protein D (surfactant protein D)

Snippet

Sponsor: Fraunhofer-Institute of Toxicology and Experimental Medicine | Conditions: Mild Intermittent Asthma (Gina 1) | NA | Status: COMPLETED